Abstract
Aims: Controversies surround various treatment variables for patients with childhood craniopharyngioma such as growth hormone (GH) replacement, which some believe can exacerbate recurrence/progression. In the multicenter prospective trial KRANIOPHARYNGEOM 2000 (www.kinderkrebsinfo.de/kranio2007) we analyzed the impact of risk factors on the incidence and time course of relapses after complete resection and tumor progressions after incomplete resection in patients with childhood craniopharyngioma.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.